3 ms·
Apparently the problem is 'The FDA grants market exclusivity to companies that are willing to take “grandfathered” compounds into compliance with their current
by tim333 11y ago
Apparently the problem is 'The FDA grants market exclusivity to companies that are willing to take “grandfathered” compounds into compliance with their current regulatory framework'. Which is why they are able to force US buyers to pay $700 a tablet for stuff which is available for a few cents in India at the same time. I think the FDA might not really be doing US consumers a favour by preventing them shopping around.